SCHEMBL24951908

SCHEMBL24951908

Cc1oc(-c2cccnc2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
HSD17B10 Q99714 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPK1 P28482 1/20 0.51
HPGD P15428 2/20 0.50
HTT P42858 2/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
KMO O15229 2/20 0.48
MKNK1 Q9BUB5 2/20 0.46
MKNK2 Q9HBH9 2/20 0.46
PIM1 P11309 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2E1 P05181 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29742813 1.00 NPC1 (0.56) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL29742828 0.87 MKNK1 (0.45) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL24951909 0.87 MKNK1 (0.45) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL28630958 0.85 NR4A2 (0.50) KDM4EALDH1A1HSD17B10SMN1; SMN2MAPK1
SCHEMBL557753 0.82 NPC1 (0.73) NPC1RAB9AKDM4EALDH1A1HSD17B10
Acetic Acid SCHEMBL28745643 0.80 NPC1 (0.69) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL28143432 0.75 KMO (0.57) KDM4EALDH1A1HTTLMNAKMO
SCHEMBL3106911 0.75 CYP3A4 (0.55) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL3649252 0.75 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL20022402 0.73 IKBKB (0.58) NPC1RAB9AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376091-A1 THIADIAZOLEAMIDE DERIVATIVES AND THEIR APPLICATIONS ZHEJIANG UNIVERSITY (CN) 2024-11-14 US disclosed
WO-2023004897-A1 THIADIAZOLE AMIDE COMPOUND AND USE THEREOF 浙江大学 2023-02-02 WO disclosed
WO-2023004897-A1 THIADIAZOLE AMIDE COMPOUND AND USE THEREOF 浙江大学 2023-02-02 WO disclosed
CN-113444081-B Thiadiazole carboxamide compounds and application thereof 浙江大学 2022-07-05 CN disclosed
CN-113444081-A Thiadiazole amide compound and application thereof 浙江大学 2021-09-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376091-A1 THIADIAZOLEAMIDE DERIVATIVES AND THEIR APPLICATIONS AR, GPER1, CYP19A1 NPC1 2750/4885RAB9A 3272/4885KDM4E 3144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.